novo-nordisk a/s-spons adr
(NOVA:Frankfurt)
Last €134.00 EUR
Change Today +0.74 / 0.56%
Volume 509.0
As of 1:56 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Earnings & Estimates Summary - NOVO-NORDISK A/S-SPONS ADR (NOVA)
Novo Nordisk A/S to Report Fiscal Year 2013 on Jan 30, 2014
Novo Nordisk A/S to Report Nine Months, 2013 on Oct 31, 2013
Novo Nordisk A/S to Report First Half, 2013 on Aug 08, 2013
No earnings announcements are currently available for NOVO-NORDISK A/S-SPONS ADR.
Quarterly Earnings & Estimates - NOVO-NORDISK A/S-SPONS ADR (NOVA)
No earnings announcements are currently available for NOVO-NORDISK A/S-SPONS ADR.
Annual Earnings & Estimates - NOVO-NORDISK A/S-SPONS ADR (NOVA)
No earnings announcements are currently available for NOVO-NORDISK A/S-SPONS ADR.
Quarterly Revenues - NOVO-NORDISK A/S-SPONS ADR (NOVA)
Annual Revenues - NOVO-NORDISK A/S-SPONS ADR (NOVA)
| Recently Viewed | |||
| NOVA:GR | €134.00 EUR | +0.74 |  |
| Company | Last | Change |
| AstraZeneca PLC | 3,383 GBp | -6.50 |
| Bristol-Myers Squibb Co | $43.30 USD | +0.53 |
| Eli Lilly & Co | $55.90 USD | -0.04 |
| Reckitt Benckiser Group PLC | 4,718 GBp | -25.00 |
| Takeda Pharmaceutical Co Ltd | ¥4,965 JPY | +10.00 |
| View Industry Companies | ||
Industry Analysis
NOVA
Industry Average
| Valuation | NOVA | Industry Range |
| Price/Earnings | 24.1x |
|
| Price/Sales | 6.8x |
|
| Price/Book | 16.0x |
|
| Price/Cash Flow | 19.5x |
|
| TEV/Sales | 5.4x |
|
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
